Literature DB >> 12207937

Mutations in the nebulin gene can cause severe congenital nemaline myopathy.

Carina Wallgren-Pettersson1, Kati Donner, Caroline Sewry, Emilia Bijlsma, Martin Lammens, Kate Bushby, Maria Luisa Giovannucci Uzielli, Elisabetta Lapi, Sylvie Odent, Zuhal Akcoren, Haluk Topaloğlu, Katarina Pelin.   

Abstract

Previously, we reported results indicating that nebulin was the gene causing the typical form of autosomal recessive nemaline (rod) myopathy. Here we describe the identification of mutations in the nebulin gene in seven offspring of five families affected by the severe congenital form of nemaline myopathy. One pregnancy was terminated on the grounds of foetal abnormality, while six affected infants died at ages ranging from the first day of life to 19 months. Only three of the six neonates were able to establish spontaneous respiration. Three had arthrogryposis. In three of the five families, the mutations were located in exon 184. These mutations are predicted to cause absence of the C-terminal part of nebulin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207937     DOI: 10.1016/s0960-8966(02)00065-2

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  25 in total

1.  A nebulin ruler does not dictate thin filament lengths.

Authors:  Angelica Castillo; Roberta Nowak; Kimberly P Littlefield; Velia M Fowler; Ryan S Littlefield
Journal:  Biophys J       Date:  2009-03-04       Impact factor: 4.033

Review 2.  Muscle giants: molecular scaffolds in sarcomerogenesis.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Maegen A Ackermann; Amber L Bowman; Solomon V Yap; Robert J Bloch
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

3.  Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1).

Authors:  Nigel G Laing; Danielle E Dye; Carina Wallgren-Pettersson; Gabriele Richard; Nicole Monnier; Suzanne Lillis; Thomas L Winder; Hanns Lochmüller; Claudio Graziano; Stella Mitrani-Rosenbaum; Darren Twomey; John C Sparrow; Alan H Beggs; Kristen J Nowak
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

Review 4.  Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus.

Authors:  Gianina Ravenscroft; Nigel G Laing; Carsten G Bönnemann
Journal:  Brain       Date:  2014-12-31       Impact factor: 13.501

5.  Nebulin-deficient mice exhibit shorter thin filament lengths and reduced contractile function in skeletal muscle.

Authors:  Marie-Louise Bang; Xiaodong Li; Ryan Littlefield; Shannon Bremner; Andrea Thor; Kirk U Knowlton; Richard L Lieber; Ju Chen
Journal:  J Cell Biol       Date:  2006-06-12       Impact factor: 10.539

Review 6.  Congenital myopathies.

Authors:  Claudio Bruno; Carlo Minetti
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

7.  Reduced thin filament length in nebulin-knockout skeletal muscle alters isometric contractile properties.

Authors:  David S Gokhin; Marie-Louise Bang; Jianlin Zhang; Ju Chen; Richard L Lieber
Journal:  Am J Physiol Cell Physiol       Date:  2009-03-18       Impact factor: 4.249

8.  Nebulin (NEB) mutations in a childhood onset distal myopathy with rods and cores uncovered by next generation sequencing.

Authors:  Mariacristina Scoto; Thomas Cullup; Sebahattin Cirak; Shu Yau; Adnan Y Manzur; Lucy Feng; Thomas S Jacques; Glenn Anderson; Stephen Abbs; Caroline Sewry; Heinz Jungbluth; Francesco Muntoni
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

Review 9.  Thin filament length regulation in striated muscle sarcomeres: pointed-end dynamics go beyond a nebulin ruler.

Authors:  Ryan S Littlefield; Velia M Fowler
Journal:  Semin Cell Dev Biol       Date:  2008-08-26       Impact factor: 7.727

10.  Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3.

Authors:  Jens Fielitz; Mi-Sung Kim; John M Shelton; Shuaib Latif; Jeffrey A Spencer; David J Glass; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.